Trials / Terminated
TerminatedNCT00782041
Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer
Phase II Study of Oxaliplatin in Combination With 5-fluorouracil (5-FU) and Folinic Acid (FA) in Patients Who Have Failed First-line Treatment for Locally Advanced or Metastatic Cervical Cancer.
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary: * To assess the overall response rate of oxaliplatin in patients with bidimensionally measurable disease at baseline. Secondary: * To assess the safety and tolerability of oxaliplatin * To assess time to progression and overall survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxaliplatin | 85 mg/m² |
| DRUG | 5-FluoroUracil | 2,000 mg/m² |
| DRUG | Folinic acid | 20 mg/m² |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2003-08-01
- First posted
- 2008-10-29
- Last updated
- 2009-09-15
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT00782041. Inclusion in this directory is not an endorsement.